TFX250117C360000
- 0.50
- 0.000.00%
Teleflex Newsroom
Should You Retain Teleflex Stock in Your Portfolio Right Now?
RBC Capital Maintains Teleflex(TFX.US) With Buy Rating, Cuts Target Price to $220
Teleflex Is Maintained at Hold by Truist Securities
Truist Financial Maintains Teleflex(TFX.US) With Hold Rating, Cuts Target Price to $200
RBC Cuts Price Target on Teleflex to $220 From $245, Keeps Outperform Rating
Pain Management Devices Global Analysis Report 2024-2034 Featuring Abbott Laboratories, Boston Scientific, Medtronic, Nevro, Baxter, OMRON, Stryker, Teleflex, ICU Medical, AtriCure, and Zynex
Mizuho Securities Maintains Teleflex(TFX.US) With Hold Rating, Cuts Target Price to $230
Express News | Teleflex Inc : Mizuho Cuts Target Price to $230 From $250
Worst Performing Stocks for Tax Loss Selling – Wolfe
Teleflex Reportedly in Talks to Buy Biotronik Stent Business
Needham Reiterates Hold on Teleflexto Hold
Needham Maintains Teleflex(TFX.US) With Hold Rating
Teleflex Expands CVC Portfolio in EMEA With New Launch: Stock to Gain?
Express News | Teleflex Inc: Expands the Pressure Injectable Arrowg+Ard Blue Plus™ CVC Portfolio in Europe, the Middle East and Africa
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
Teleflex (NYSE:TFX) Sheds US$381m, Company Earnings and Investor Returns Have Been Trending Downwards for Past Five Years
Why Teleflex (TFX) Is a Top Value Stock for the Long-Term
Market Chatter: Teleflex in Talks to Buy Biotronik's Vascular Intervention Unit
Teleflex Is Said To Offer €500M To €1B For Biotronik Unit
Do Wall Street Analysts Like Teleflex Stock?